About the Authors
- Steen Knudsen
-
* E-mail: steen@medical-prognosis.com
Affiliation Medical Prognosis Institute, Hørsholm, Denmark
- Thomas Jensen
-
Affiliation Medical Prognosis Institute, Hørsholm, Denmark
- Anker Hansen
-
Affiliation Medical Prognosis Institute, Hørsholm, Denmark
- Wiktor Mazin
-
Affiliations Medical Prognosis Institute, Hørsholm, Denmark, Now at the Department of Clinical Epidemiology at Aarhus University Hospital, Aarhus C, Denmark
- Justin Lindemann
-
Affiliation Astrazeneca UK Limited, Oncology iMED, Alderley Park, Cheshire, United Kingdom
- Irene Kuter
-
Affiliation Massachusetts General Hospital, Massachusetts, Boston, United States of America
- Naomi Laing
-
Affiliation Astrazeneca R&D Boston, Waltham, United States of America
- Elizabeth Anderson
-
Affiliations Astrazeneca UK Limited, Oncology iMED, Alderley Park, Cheshire, United Kingdom, Now at Boehringer-Ingelheim RCV GmbH & Co KG, Vienna, Austria
Competing Interests
The authors have read the journal's policy and have the following conflicts. All authors declare past or present primary employment or ownership in a company (Astrazeneca or Medical Prognosis Institute) that has a potential to benefit from these results. Medical Prognosis Institute holds a patent application on the subject matter. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SK JL EA. Performed the experiments: TJ AH IK. Analyzed the data: SK WM NL EA. Wrote the paper: SK NL EA.